57 votes is more than I thought. But unfortunately it did not pass for those with private insurance. Needed 60 votes because of the point of order. Capping insulin to $35 is not going to happen for those with insurance.
Still hoping for a miracle. @DemFromCT — your comment gives me some hope.
Patients with cancers such as myeloma and CLL will benefit greatly from new changes:
Out of pocket costs will be capped at $2000 starting 2025. A game changer. kff.org/medicare/issue…
Patients will start seeing benefit even in 2024. Patients pay 5% of the cost of the drug once they’ve spent about $7000 a year (the catastrophic threshold).
It’s not hard to hit catastrophic threshold quickly when drugs cost $15,000 a month.
This 5% cost sharing ends in 2024
But if copays are capped and Medicare cannot negotiate it will allow Pharma to hike prices even more rapidly. Why?
Coz it will effectively silence the most important voice against unreasonably high drug prices: the voice of patients. Since their cost will stay constant.
3) The US plan to keep insulin price to $35 for Medicare beneficiaries is still intact. It is part of the historic healthcare reforms passed yesterday.
Breaking: Finally it has happened. Senate has passed a bill that is almost certain to become law. What it does:
1) Allows Medicare to negotiate drug prices 2) Prevents price increases on drugs Medicare buys.. 3) Caps out-of-pocket drug costs for seniors to max of $2000 per year
1) Medicare negotiation is critical. It is what all other developed countries do. I welcome this even though it s more modest than I wanted.
2) Preventing the ability of drug companies to increase prices on the same drug year after year is huge. This is something that will greatly benefit seniors and the public. What happened in the last decade, see below, will be slowed down.
If you want to know how powerful Pharma lobbying is, look no further than insulin.#Insulin4All
Though insulin costs 10 times more than in other countries, is needed for survival in diabetes, despite countless articles written, let’s see how many oppose capping the price to $35.
Insulin prices compared to prices of other things we use as well illustrated by @lollydaggle years ago.
Some states have acted. have introduced the oxymoronic idea of “authorized generics”. But we need a national solution.
Insulin is the Achilles heel of Pharma and PBMs. There is absolutely no justification.
118 of the nations leading oncologists call for Medicare negotiation of prescription drug prices— as far back as 2015! Read the petition. @MayoProceedings
As people who lead trials of new drugs we know what hurts innovation and what doesn't.
Medicare negotiation is good not only for seniors but the entire public.
We will have more truly innovative and effective drugs because Pharma will not have the easy way out that it currently does of high prices regardless of how good a drug is. 3/